Madelyn D. Landis

University of Pennsylvania — United States

Medicine · Health Sciences

6h-index228citations21works11.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal cell carcinoma treatment(7), Cancer, Hypoxia, and Metabolism(7), Cancer, Lipids, and Metabolism(5), Metabolomics and Mass Spectrometry Studies(4), Adipokines, Inflammation, and Metabolic Diseases(3)

Publications21 total

Opposing effects of systemic and pancreas-specific inhibition of BCKDK on pancreatic carcinogenesis
2025Open Access
Author Correction: Obesity induces PD-1 on macrophages to suppress anti-tumour immunity
Nature·2024· 2 citedOpen Access
Peripheral T Cell Development and Immunophenotyping of Twins with Heterozygous <i>FOXN1</i> Mutations
ImmunoHorizons·2024· 1 citedOpen Access
HIF-2α expression and metabolic signaling require ACSS2 in clear cell renal cell carcinoma
Journal of Clinical Investigation·2024· 15 citedOpen Access
Obesity induces PD-1 on macrophages to suppress anti-tumour immunity
Nature·2024· 122 citedOpen Access
Author response: Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
2024Open Access
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
eLife·2024Open Access
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
2024Open Access
Author response: Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
2024Open Access
VHL loss reprograms the immune landscape to promote an inflammatory myeloid microenvironment in renal tumorigenesis
Journal of Clinical Investigation·2024· 15 citedOpen Access
Reviewer #3 (Public Review): Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
2024Open Access
Reviewer #1 (Public Review): Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
2024Open Access
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
eLife·2024· 14 citedOpen Access
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
2024Open Access
Reviewer #2 (Public Review): Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
2024Open Access
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
2023Open Access
Nutrient inputs and social metabolic control of T cell fate
Cell Metabolism·2023· 33 citedOpen Access
Abstract PR016: Systemic T cell metabolic and effector function changes following treatment with PD1 and CTLA4 in patients with kidney cancer
Cancer Research·2023
Differential Effects of Glutamine Inhibition Strategies on Antitumor CD8 T Cells
The Journal of Immunology·2023· 22 citedOpen Access
PD-1 is induced on tumor-associated macrophages in obesity to directly restrain anti-tumor immunity
2022· 2 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Jeffrey C. Rathmell(20), Kathryn E. Beckermann(17), W. Kimryn Rathmell(17), Bradley I. Reinfeld(15), Rachel A. Hongo(13), Alexander Muir(11), Keene L. Abbott(10), Ahmed Ali(10), Amy Deik(10), Sonu Subudhi(10), Kirsten Young(10), Tenzin Kunchok(10), Christopher S. Nabel(10), Kayla D. Crowder(10), Johnathan R. Kent(10), Maria Lucia L. Madariaga(10), Rakesh K. Jain(10), Caroline A. Lewis(10), Clary B. Clish(10), Matthew G. Vander Heiden(10)